3
Participants
Start Date
October 31, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
September 30, 2026
Energy Drink A + Placebo Capsule
1000 mL caffeine- and taurine-containing commercially available beverage (Formula A) consumed with placebo capsule
Placebo Drink + Moxifloxacin Capsule
Placebo drink with 400 mg moxifloxacin capsule
Placebo Drink + Caffeine Capsule
Placebo drink with 320 mg caffeine capsule
Placebo Drink + Placebo Capsule
Placebo drink with placebo capsule
Energy Drink B
568 mL caffeine- and taurine-containing commercially available beverage (Formula B)
Control Product + Taurine
Control product with 4000 mg taurine powder
Control Product + Caffeine + Taurine
Control product with 320 mg caffeine + 4000 mg taurine powder
Lower Dose Energy Drink A
591 mL caffeine- and taurine-containing commercially available beverage (Formula A)
RECRUITING
University of the Pacific, Stockton
University of the Pacific
OTHER